Research Article

Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients

Volume: 10 Number: 36 March 26, 2019
EN TR

Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients

Abstract

Aim: Stanford Type B acute aortic dissection (Type B-AAD) has a higher mortality among the cardiovascular diseases and the complexity of its treatment is an important challenge. The duration of dissection, whether it is complicated or uncomplicated play a determinant role in the treatment of the disease. In this study, we evaluated the results of the patients that we followed and we treated due to the Type B acute aortic dissection.

Materials and Methods: The study was conducted in a single center and retrospectively. The treatment strategy of the patients was determined with respect to be acute or chronic and to be complicated or uncomplicated. The patients were treated via medical treatment, thoracic endovascular aortic repair (TEVAR) or open surgery and then they were followed. The mortality and the morbidity causes of the patients were recorded.

Result:Totally, 23 patients were treated due to Type B acute aortic dissection. The mean age of the patients was 58.21±14.17. The majority of the followed patients (16 patients (69.5%)) were followed with medical treatment. The patients who were followed with TEVAR treatment were in the second rank. The number of the TEVAR patients was 5 (21.7%). Two patients were treated with open surgery. 30-day survival was observed in 20 (86.9%) patients. The total mortality was seen in 3 (13%) patients.

Conclusion: The twenty five percent of the patients who refer due to Type B acute aortic dissection admit due to malperfusion syndrome or hemodynamic instability. Organ malperfusion and hemodynamic instability are the most important causes of deaths of these patients. Hence, the early diagnosis of the patient and its optimal treatment is life-saving. If the patients who are treated due to the Type B acute aortic dissection are in uncomplicated type, medical treatment is in the forefront. In complicated patients, TEVAR or open surgery are recommended. In our Type B acute aortic dissection group which consists of 23 patients, the total mortality ratio was seen in 3 (13%) patients. The ratios for renal failure and for plegia were found as 4.3%. In thoracic endovascular aortic repair, no mortality was found.

In conclusion, we primarily recommend conventional medical treatment for the patients in uncomplicated type in the treatment of the Type B acute aortic dissection patients. In the patients in complicated type we recommend TEVAR treatment. Since the necessary equipment for the TEVAR could not be ensured, we recommend open surgery for the emergency cases.

Keywords

References

  1. Qin YL, Wang F, Li TX, Ding W, Deng G, Xie B, Teng GJ. Endovascular repair compared with medical management of patients with uncomplicated type B acute aortic dissection. Journal of the American College of Cardiology. 2016;67:2835-2842.
  2. Scott AJ, Bicknell CD. Contemporary management of acute type B dissection. European Journal of Vascular and Endovascular Surgery. 2016;51:452-459.
  3. Fattori R, Cao P, De Rango P, Czerny M, Evangelista A, Nienaber C, Rousseau H, Schepens M. Interdisciplinary expert consensus document on management of type B aortic dissection. Journal of the American College of Cardiology.2013;61:1661-1678.
  4. Steuer J, Björck M, Mayer D, Wanhainen A, Pfammatter T, Lachat M. Distinction between acute and chronic type B aortic dissection: is there a sub-acute phase? Eur J Vasc Endovasc Surg. 2013;45:627-631.
  5. Afifi RO, Sandhu HK, Leake SS, Boutrous, ML, Kumar III V, et al. Outcomes of patients with acute type B (DeBakey III) aortic dissection: a 13-year, single-center experience. Circulation. 2015;132:748-754.
  6. Fattori R, Tsai TT, Myrmel T, Evangelista A, Cooper JV,et al. Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC: Cardiovascular Interventions. 2008;1:395-402.
  7. Trimarchi S. Eagle KA, Nienaber CA, Pyeritz RE, Jonker FH,et al. International Registry of Acute Aortic Dissection (IRAD) Investigators. Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2010;122:1283-9.
  8. Numan F,Gülşen F, Arbatlı H, Yılmaz O,Solak S. Akut komplike tip B aortik diseksiyonların endovasküler tedavisi. Türk Göğüs Kalp Damar Cer Derg.2011;19:41-45.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

March 26, 2019

Submission Date

December 21, 2018

Acceptance Date

March 5, 2019

Published in Issue

Year 2019 Volume: 10 Number: 36

APA
Demir, D., & Kahraman, N. (2019). Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients. The Medical Journal of Mustafa Kemal University, 10(36), 1-5. https://doi.org/10.17944/mkutfd.499838
AMA
1.Demir D, Kahraman N. Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients. mkutfd. 2019;10(36):1-5. doi:10.17944/mkutfd.499838
Chicago
Demir, Deniz, and Nail Kahraman. 2019. “Short-Term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients”. The Medical Journal of Mustafa Kemal University 10 (36): 1-5. https://doi.org/10.17944/mkutfd.499838.
EndNote
Demir D, Kahraman N (March 1, 2019) Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients. The Medical Journal of Mustafa Kemal University 10 36 1–5.
IEEE
[1]D. Demir and N. Kahraman, “Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients”, mkutfd, vol. 10, no. 36, pp. 1–5, Mar. 2019, doi: 10.17944/mkutfd.499838.
ISNAD
Demir, Deniz - Kahraman, Nail. “Short-Term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients”. The Medical Journal of Mustafa Kemal University 10/36 (March 1, 2019): 1-5. https://doi.org/10.17944/mkutfd.499838.
JAMA
1.Demir D, Kahraman N. Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients. mkutfd. 2019;10:1–5.
MLA
Demir, Deniz, and Nail Kahraman. “Short-Term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients”. The Medical Journal of Mustafa Kemal University, vol. 10, no. 36, Mar. 2019, pp. 1-5, doi:10.17944/mkutfd.499838.
Vancouver
1.Deniz Demir, Nail Kahraman. Short-term and Midterm Treatment Results in Stanford Type-B Acute Dissection Patients. mkutfd. 2019 Mar. 1;10(36):1-5. doi:10.17944/mkutfd.499838